 |
|
Early Detection of Thick Melanomas in the United States
Beware of the Nodular Subtype
Marie-France Demierre, MD, FRCPC;
Connie Chung, MD, PhD;
Donald R. Miller, ScD;
Alan C. Geller, MPH, RN
Arch Dermatol. 2005;141:745-750.
Background Incidence and mortality of melanoma in the United States have risen steeply. Part of this mortality increase may be related to late detection of biologically aggressive nodular melanomas. We determined trends in distribution of thin and thick melanoma, with emphasis on the histopathologic subtype nodular melanoma.
Methods Surveillance, Epidemiology, and End Results melanoma incidence data for whites were obtained for 1988 through 1999 and stratified according to histologic subtype: lentigo maligna melanoma, superficial spreading melanoma, nodular melanoma, other, and not otherwise specified (NOS); thickness: 0-0.99 mm, 1.00 mm-1.99 mm, and  2.0 mm; patient age (0-49, 50+); gender; and year (1988-1991, 1992-1995, 1996-1999). Comparison of tumor thickness between strata was defined by year of diagnosis, sex, age, and histologic subtype.
Results The number of new melanoma cases in a 3-year period increased 60% from 1988-1991 (n = 9132) to 1996-1999 (n = 14 575). The proportion of thick melanomas (2 mm) remained relatively stable during the 12 study years. Nodular melanoma comprised 9% of all recorded cases but 34% of melanomas 2 mm or larger, including melanoma not otherwise specified (NOS), and nearly 50% of all melanomas 2 mm or larger when NOS cases were excluded. In contrast, superficial spreading melanoma was almost uniformly diagnosed as an early tumor, mostly (77%) presenting as thin melanoma (<1 mm) and with only 7% presenting as thick melanoma (2 mm).
Conclusions A substantial number of thick melanomas in the United States are of the nodular subtype, and median thickness of nodular melanoma has not changed during the 12 years of study. New strategies are needed to decrease the incidence of thick melanoma in the United States.
Author Affiliations: Department of Dermatology, Boston University School of Medicine (Drs Demierre, Chung, and Miller and Mr Geller), and Departments of Health Services (Dr Miller) and Epidemiology (Mr Geller), Boston University School of Public Health, Boston, Mass.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Melanoma in Middle-aged and Older Men: A Multi-institutional Survey Study of Factors Related to Tumor Thickness
Swetter et al.
Arch Dermatol 2009;145:397-404.
ABSTRACT
| FULL TEXT
Acral Lentiginous Melanoma: Incidence and Survival Patterns in the United States, 1986-2005
Bradford et al.
Arch Dermatol 2009;145:427-434.
ABSTRACT
| FULL TEXT
Seventy Seconds Inadequate for a Complete Skin Examination--Reply
Marghoob et al.
Arch Dermatol 2008;144:1659-1660.
FULL TEXT
In Vivo Microscopic Features of Nodular Melanomas: Dermoscopy, Confocal Microscopy, and Histopathologic Correlates
Segura et al.
Arch Dermatol 2008;144:1311-1320.
ABSTRACT
| FULL TEXT
Shedding of Distinct Cryptic Collagen Epitope (HU177) in Sera of Melanoma Patients
Ng et al.
Clin. Cancer Res. 2008;14:6253-6258.
ABSTRACT
| FULL TEXT
Melanoma in Older Patients
Lange and Balch
Am Soc Clin Oncol Ed Book 2008;2008:399-402.
ABSTRACT
| FULL TEXT
The Influence of Marital Status on Stage at Diagnosis and Survival of Older Persons With Melanoma
Reyes Ortiz et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2007;62:892-898.
ABSTRACT
| FULL TEXT
Gene Expression Signatures for Tumor Progression, Tumor Subtype, and Tumor Thickness in Laser-Microdissected Melanoma Tissues
Jaeger et al.
Clin. Cancer Res. 2007;13:806-815.
ABSTRACT
| FULL TEXT
Growth Rate, Early Detection, and Prevention of Melanoma: Melanoma Epidemiology Revisited and Future Challenges
Lipsker
Arch Dermatol 2006;142:1638-1640.
FULL TEXT
Cutaneous Malignant Melanoma
Cummins et al.
Mayo Clin Proc. 2006;81:500-507.
ABSTRACT
| FULL TEXT
|
